ARCHIVES

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

This article is from The Cancer Letter archive.

Vol. 21 No. 07 | February 17, 1995

Download PDF Visit The Full Archive

Related Articles

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

In Brief: NCI Study Finds No Relation Of Fluoridated Water To Cancer Incidence In U.S. Counties

December 5, 1975

In Brief: NCI To Leave Blair, Landlow Building; House To Hold Hearings March 5 On NCI’s 1998 Budget

February 13, 1987

Hatfield Asks AACR to Join In forming “Triangle Coalition”

June 23, 1989

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

August 2, 1996

NIH Considering Longer grant Award Periods; CCIRC’s New Bosses Crack Dow On Conferences

November 10, 1978